Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Yoshida

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulinE M Yoshida, S R Erb, N Partovi, et al.
Annals of Surgery|August 18, 1999
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigenY Chen, G J McKenna, E M Yoshida, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case seriesE M Yoshida, A K Buczkowski, S M Sirrs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2001
Analysis of causes of death in liver transplant recipients who survived more than 3 yearsJ Pruthi, K A Medkiff, K T Esrason, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 29, 1998
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-upE M Yoshida, M M Ma, J E Davis, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2008
Survival after liver transplantation for hepatitis C is unchanged over two decades in CanadaK Ds Watt, K W Burak, M Deschênes, et al.
Neurology|May 29, 2001
Fulminant liver failure during interferon beta treatment of multiple sclerosisE M Yoshida, S L Rasmussen, U P Steinbrecher, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 7, 2000
Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysisE M Yoshida, N R Caron, A K Buczkowski, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceS S Lee, V G Bain, K Peltekian, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulinE M Yoshida, S R Erb, N Partovi, et al.
Annals of Surgery|August 18, 1999
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigenY Chen, G J McKenna, E M Yoshida, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 2000
Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case seriesE M Yoshida, A K Buczkowski, S M Sirrs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2001
Analysis of causes of death in liver transplant recipients who survived more than 3 yearsJ Pruthi, K A Medkiff, K T Esrason, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 29, 1998
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-upE M Yoshida, M M Ma, J E Davis, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2008
Survival after liver transplantation for hepatitis C is unchanged over two decades in CanadaK Ds Watt, K W Burak, M Deschênes, et al.
Neurology|May 29, 2001
Fulminant liver failure during interferon beta treatment of multiple sclerosisE M Yoshida, S L Rasmussen, U P Steinbrecher, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 7, 2000
Indications for liver transplantation in British Columbia's Aboriginal population: a 10-year retrospective analysisE M Yoshida, N R Caron, A K Buczkowski, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceS S Lee, V G Bain, K Peltekian, et al.
Pageof 10